Subscribe to RSS
DOI: 10.1055/a-2765-5414
The Impact of Age and Presentation with Vision Loss in Pituitary Adenomas: A Retrospective Analysis
Authors
Abstract
Objective
In this single-center study, we aimed to determine if age at presentation was associated with vision loss and if this effect could be explained by tumor volume and/or cavernous sinus invasion.
Methods
We conducted a retrospective chart review of patients surgically treated for a pituitary adenoma between 2017 and 2023 at an academic tertiary care center. A total of 123 patients were included in this study. Tumor volume was calculated using the traditional formula: (AP × CC × TR)/2, where AP, CC, and TR refer to the three dimensions of the tumor in centimeters. Visual loss was taken as a visual field deficit within 1 year prior to resection.
Results
Our analysis showed that those with vision loss at presentation were, on average, older than those who did not have vision loss at presentation (57.2 ± 13.7 years [n = 82] vs. 49.9 ± 16.8 years [n = 41]; p = 0.02*). However, using simple linear regression, there was no correlation between age and tumor volume (r 2 = 0.02; p = 0.18). In addition, a critical age of 42.5 was determined to be when patients with pituitary adenomas begin to have a significantly increased likelihood of suffering from vision loss.
Conclusion
Older patients with pituitary tumors were more likely to present with vision loss, but this was not associated with increased tumor volume or cavernous sinus invasion. Further research is needed to determine whether age-related thinning and increased vulnerability of the optic apparatus contribute to this finding.
Publication History
Received: 27 February 2025
Accepted: 07 September 2025
Accepted Manuscript online:
05 December 2025
Article published online:
12 December 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Lake MG, Krook LS, Cruz SV. Pituitary adenomas: an overview. Am Fam Physician 2013; 88 (05) 319-327
- 2 Ezzat S, Asa SL, Couldwell WT. et al. The prevalence of pituitary adenomas: a systematic review. Cancer 2004; 101 (03) 613-619
- 3 Molitch ME. Nonfunctioning pituitary tumors. Handb Clin Neurol 2014; 124: 167-184
- 4 Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA 2017; 317 (05) 516-524
- 5 Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 2006; 91 (12) 4769-4775
- 6 Nishioka H, Inoshita N. New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors. Brain Tumor Pathol 2018; 35 (02) 57-61
- 7 Vance ML. Diagnosis, management, and prognosis of pituitary tumors. Thapar K, Kovacs K, Scheithauer B, Lloyd RV. Diagnosis and management of pituitary tumors. Totowa. 2001:165–172.
- 8 Nieman LK, Biller BM, Findling JW. et al. The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93 (05) 1526-1540
- 9 Melmed S, Casanueva FF, Hoffman AR. et al; Endocrine Society. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96 (02) 273-288
- 10 Arafah BM, Prunty D, Ybarra J, Hlavin ML, Selman WR. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab 2000; 85 (05) 1789-1793
- 11 Monteiro ML, Zambon BK, Cunha LP. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression. Can J Ophthalmol 2010; 45 (04) 404-408
- 12 Ho R-W, Huang H-M, Ho J-T. The influence of pituitary adenoma size on vision and visual outcomes after trans-sphenoidal adenectomy: a report of 78 cases. J Korean Neurosurg Soc 2015; 57 (01) 23-31
- 13 Lee JP, Park IW, Chung YS. The volume of tumor mass and visual field defect in patients with pituitary macroadenoma. Korean J Ophthalmol 2011; 25 (01) 37-41
- 14 Kan E, Kan EK, Atmaca A, Atmaca H, Colak R. Visual field defects in 23 acromegalic patients. Int Ophthalmol 2013; 33 (05) 521-525
- 15 Anderson D, Faber P, Marcovitz S, Hardy J, Lorenzetti D. Pituitary tumors and the ophthalmologist. Ophthalmology 1983; 90 (11) 1265-1270
- 16 Ebersold MJ, Quast LM, Laws Jr ER, Scheithauer B, Randall RV. Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 1986; 64 (05) 713-719
- 17 RW H. Ocular manifestations produced by adenomas of the pituitary gland: analysis of 1000 cases. Diagnosis and treatment of pituitary tumors. 1973;
- 18 Andersen GJ. Aging and vision: changes in function and performance from optics to perception. Wiley Interdiscip Rev Cogn Sci 2012; 3 (03) 403-410
- 19 Jackson GR, McGwin Jr G, Phillips JM, Klein R, Owsley C. Impact of aging and age-related maculopathy on inactivation of the a-wave of the rod-mediated electroretinogram. Vision Res 2006; 46 (8–9): 1422-1431
- 20 Zhu X, Brown B, Rife L, Craft CM. Slowed Photoresponse Recovery and Age-Related Degeneration in Cones Lacking Gprotein-Coupled Receptor Kinase 1. Springer; 2006: 133-139
- 21 Mann M, Haq W, Zabel T, Guenther E, Zrenner E, Ladewig T. Age-dependent changes in the regulation mechanisms for intracellular calcium ions in ganglion cells of the mouse retina. Eur J Neurosci 2005; 22 (11) 2735-2743
- 22 Curcio CA, Millican CL, Allen KA, Kalina RE. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci 1993; 34 (12) 3278-3296
- 23 Gao H, Hollyfield JG. Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1992; 33 (01) 1-17
- 24 Patel NB, Lim M, Gajjar A, Evans KB, Harwerth RS. Age-associated changes in the retinal nerve fiber layer and optic nerve head. Invest Ophthalmol Vis Sci 2014; 55 (08) 5134-5143
- 25 Jahangiri A, Lamborn KR, Blevins L, Kunwar S, Aghi MK. Factors associated with delay to pituitary adenoma diagnosis in patients with visual loss. J Neurosurg 2012; 116 (02) 283-289
- 26 Gjørup T, Hendriksen C, Lund E, Strømgård E. Is growing old a disease? A study of the attitudes of elderly people to physical symptoms. J Chronic Dis 1987; 40 (12) 1095-1098
- 27 Keller ML, Leventhal H, Prohaska TR, Leventhal EA. Beliefs about aging and illness in a community sample. Res Nurs Health 1989; 12 (04) 247-255
- 28 Wormald R. Delivery of eye care to the elderly: practical considerations. Community Eye Health 1999; 12 (29) 6-7
- 29 Quillen DA. Common causes of vision loss in elderly patients. Am Fam Physician 1999; 60 (01) 99-108
